{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-25-000886","form_type":"8-K","ticker":"LCTC","cik":"0001493137","company_name":"Lifeloc Technologies, Inc","filed_at":"2025-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.441120+00:00","generated_at":"2026-05-21T03:07:19.376272+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Lifeloc Q1 revenue up 6% to $2.28M, net loss $(293k) from $(284k) YoY","bullets":["Q1 net revenue $2.277M (+6% YoY); net loss $(293k) or $(0.11) per diluted share.","Gross margin improved to 39.9% from 38.8%; R&D spending >20% of revenue for SpinDx development.","SpinDx beta testing with Anschutz Medical Center imminent; commercial launch targeted for 2026.","Applied for OTCID listing on OTC Markets, effective July 1, 2025, replacing OTC Pink."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-25-000886","json":"https://secwatch.observer/filing/0001079973-25-000886.json","markdown":"https://secwatch.observer/filing/0001079973-25-000886.md","text":"https://secwatch.observer/filing/0001079973-25-000886.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1493137/000107997325000886/0001079973-25-000886-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1493137/000107997325000886/lctc_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T03:07:19.376272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}